Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Macfarlane

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2016
Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitorsJ N Mahlangu, T A Andreeva, D E Macfarlane, et al.
British Journal of Haematology|August 1, 1975
The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluationD E Macfarlane, P N Walsh, D C Mills, et al.
Cancer Research|October 1, 1989
Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytesD Gailani, F J Cadwell, P S O'Donnell, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Letter: A method for assaying von Willebrand factor (ristocetin cofactor)D E Macfarlane, J Stibbe, E P Kirby, et al.
British Journal of Cancer|January 1, 1997
Up-regulation of p21WAF1 expression in myeloid cells is activated by the protein kinase C pathwayJ Schwaller, U R Peters, T Pabst, et al.
The Journal of Infection|September 1, 1981
Congenital toxoplasmosis: a prospective survey in the West of ScotlandK A Williams, J M Scott, D E Macfarlane, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotidesL Strekowski, O Zegrocka, M Henary, et al.
Annals of Internal Medicine|July 15, 1994
Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial GroupT E Spiro, G J Johnson, M J Christie, et al.
British Journal of Haematology|April 1, 1975
Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to plateletsP N Walsh, D C Mills, F I Pareti, et al.
Acta Haematologica|January 1, 1984
Acute graft-versus-host disease resulting from normal donor blood transfusionsL J Burns, M W Westberg, C P Burns, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2016
Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitorsJ N Mahlangu, T A Andreeva, D E Macfarlane, et al.
British Journal of Haematology|August 1, 1975
The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluationD E Macfarlane, P N Walsh, D C Mills, et al.
Cancer Research|October 1, 1989
Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytesD Gailani, F J Cadwell, P S O'Donnell, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Letter: A method for assaying von Willebrand factor (ristocetin cofactor)D E Macfarlane, J Stibbe, E P Kirby, et al.
British Journal of Cancer|January 1, 1997
Up-regulation of p21WAF1 expression in myeloid cells is activated by the protein kinase C pathwayJ Schwaller, U R Peters, T Pabst, et al.
The Journal of Infection|September 1, 1981
Congenital toxoplasmosis: a prospective survey in the West of ScotlandK A Williams, J M Scott, D E Macfarlane, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotidesL Strekowski, O Zegrocka, M Henary, et al.
Annals of Internal Medicine|July 15, 1994
Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial GroupT E Spiro, G J Johnson, M J Christie, et al.
British Journal of Haematology|April 1, 1975
Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to plateletsP N Walsh, D C Mills, F I Pareti, et al.
Acta Haematologica|January 1, 1984
Acute graft-versus-host disease resulting from normal donor blood transfusionsL J Burns, M W Westberg, C P Burns, et al.
Pageof 9